Medical Devices Startups

NuGen MD develops needle-free technologies and other medical delivery products for patients and practitioners. The company is pursuing regulatory approval in multiple countries.

1 investor

Numotion is North America's largest provider of mobility products and services, offering Complex Rehab Technology, urology supplies, speech solutions, and workers' compensation services to individuals with mobility limitations and complex medical needs. The company serves over 500,000 customers annually through a nationwide network of 150+ locations and brands including SpinLife and CorLife.

1 investor

NuPulseCV develops the Voyage device, a cardiac support technology aimed at patients with heart failure who are treated at both major institutions and community hospitals. The company is guided by a scientific advisory board of clinically active cardiologists and cardiac surgeons.

1 investor

Nurami Medical develops surgical sealants and grafts using electrospun nanofiber scaffolds made from resorbable polymers to support tissue engineering and regeneration. The company creates customized biomimetic scaffolds that mimic natural tissue structure for surgical and wound healing applications.

1 investor

Nurea develops medical imaging software that automatically reconstructs and analyzes the arterial tree from DICOM CT scans to support the diagnosis and follow-up of vascular diseases such as aortic aneurysms. Its tools are designed for physicians and integrate with existing PACS, workstations, and imaging software.

1 investor

Headsafe is a brain health technology platform that delivers objective brain assessment for concussion and injury detection in clinical and field settings. The company's flagship product, Nurochek, is an FDA-cleared portable brain scanner using EEG and VEP technology designed for use in emergency rooms, urgent care, ambulances, and sideline settings.

1 investor

Nurotron develops implantable neurostimulation and neuromodulation medical devices for treating sensory and neurological disorders, including cochlear implants for hearing restoration, retinal implants for vision restoration, sacral neuromodulation for bladder dysfunction, and deep brain stimulation for movement disorders.

1 investor

Nutrix develops digital health technology focused on hormonal intelligence and preventive health, including the cortiSense sensor and the gSense platform for cortisol monitoring and diabetes/obesity management. The company combines AI, nanotechnology, and medical expertise to shift care from treating illness toward preventive healthcare.

1 investor

Nutromics is developing a "lab-on-a-patch" that combines DNA-based (EAB) sensors with microneedles to continuously monitor multiple targets in the body for diagnostic and treatment use. The technology aims to provide real-time trend data for dynamic targets and fast-moving conditions; the product is still in development and not yet approved by regulators.

1 investor

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD). The treatment targets COPD patients with lung hyperinflation and low emphysema, aiming to preserve lung function, reduce breathlessness, and lower exacerbations.

1 investor

NuVasive provides intraoperative neuromonitoring (IONM) services and implantable orthopedic and spinal devices for hospitals, surgeons, and patients, supported by board-certified neurologists and neurophysiologists. The company is transitioning its operations to Globus Medical.

1 investor

NuVision develops ocular biotherapies rooted in translational research from the University of Nottingham, aiming to provide patients with immediate access to innovative eye surface repair and regeneration treatments. The company operates across the UK, Middle East, Nordics, and central Europe.

1 investor

Nuvomed is a family-operated company that develops and distributes affordable health and wellness devices, with a focus on hearing enhancement, physical therapy, and mental wellness. It sells holistically therapeutic products to consumers across the United States, originally supplying small pharmacies.

1 investor

NUWEIGH designs, manufactures, and services industrial weighing equipment and software management systems for the weighing industry in Australia. The company provides weighbridges, scales, calibration services, and related technical support to industrial clients.

1 investor

NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model. Operating with partner Treo Ventures, it has created companies such as ShiraTronics, Avivomed, iVEAcare, and iRiva Medical, with offices in Ireland, Minneapolis, and Silicon Valley.</parameter> <parameter name="founders">[{"full_name": "Mudit K. Jain", "title": "Founder and CEO"}, {"full_name": "Lynn Elliott", "title": "Founder and CTO"}]</parameter> <parameter name="hq_city">Minneapolis

1 investor

nView medical develops the nView s1, a low-dose 3D imaging and surgical navigation system with true-map navigation and AI-based intraoperative planning, guidance, and quality control. The system is designed for pediatric and adult surgery, used by children's hospitals and surgical teams.

1 investor

Nykode Therapeutics is a biotechnology company; this investor relations page provides shareholder information, financial reports, and corporate governance details but does not describe the company's specific products or therapeutic focus.

1 investor

Nyxoah is a medical device manufacturer focused on product security and vulnerability disclosure procedures for its healthcare devices and services. The page outlines the company's responsible disclosure policy for security researchers to report vulnerabilities affecting patients, caregivers, operators, and customers.

1 investor

Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions. Its lead program focuses on hematological malignancies, with a seed round supporting preclinical work toward an IND-ready clinical candidate.

1 investor

Oak Hill Bio develops therapies for patients with rare diseases, supported by experienced life science investors.

1 investor

NIRSit Lite Kids is a portable, wireless neuroimaging device designed for brain measurement research in children, supporting applications in developmental disorder research, educational assessment, neurofeedback training, and AR/VR effectiveness testing.

1 investor

Obento offers a health-focused experience, though specific details about its service model, customer type, and industry positioning are not clearly stated on the visible page content.

1 investor

Obulytix develops Precision Lysin Therapeutics, a novel class of engineered biologics designed to target multidrug-resistant Gram-negative bacteria for severe bloodstream and lung infections. The company was founded as a spin-off from Ghent University and KU Leuven to address antimicrobial resistance in healthcare.

1 investor

Orthopedic Care Partners is a private equity-backed platform providing integrated musculoskeletal healthcare services across multiple orthopedic clinics and affiliated practices in the US. The company offers a comprehensive suite of orthopedic surgery, sports medicine, interventional pain management, and ancillary MSK services while allowing acquired practices to maintain their distinct identities and clinical autonomy.

1 investor